SIGNIFOR SIGNIFOR

Patient Support Icon

For patient support, please call: 888.454.8860

Target the source

How SIGNIFOR works

SIGNIFOR┬« (pasireotide) is the first and only subcutaneously administered treatment that works in the pituitary gland to help reduce cortisol and calm the signs and symptoms of Cushing’s disease.

  • Cushing’s disease is caused by a benign tumor in the pituitary gland, called a pituitary adenoma, that can cause too much hormone production
  • The pituitary gland is part of the endocrine system that releases hormones that regulate the functions of other endocrine glands
  • In people who develop this type of tumor, their bodies make too much of a certain hormone called cortisol
  • Excess cortisol causes the problems associated with Cushing’s disease

SIGNIFOR reduces cortisol levels by targeting key somatostatin (SST) receptors in the pituitary adenoma cells.

  • SIGNIFOR targets 4 of the 5 SST receptors, and works primarily at SST5 and SST2
  • SST5 is known to be the most common SST receptor in Cushing’s disease tumors
Piuitary gland diagram

SIGNIFOR directly targets the pituitary gland tumor

binding to key receptors that are most responsible for excess cortisol to help reduce cortisol levels.

What SIGNIFOR does

Up to 26% of patients achieved normal
cortisol levels in a medical study:

15% who took the 0.6-mg dose twice daily had mean urinary free cortisol levels return to normal, 26% of people who took the 0.9-mg dose twice daily had mean urinary free cortisol levels return to normal

ABOUT THE STUDY: SIGNIFOR 0.6 mg and 0.9 mg were evaluated over a 6-month period in a randomized study in 162 patients with persistent or recurrent Cushing’s disease despite pituitary surgery or patients for whom surgery was not indicated or who had refused surgery.

SIGNIFOR reduced cortisol levels in both treatment groups

Approximately 15%-26% of patients taking SIGNIFOR had their cortisol levels return to normal. Cortisol decreases of approximately 20%-40% were seen in patients even though some did not return to normal.

SIGNIFOR has been shown to help improve the signs
and symptoms of Cushing’s disease, including

weight
waist circumference
body mass index
blood pressure
Weight

Weight

Waist circumference

Waist circumference

Body mass index

Body mass index

Blood pressure

Blood pressure

In studies, individual patients showed different amounts of improvement in the symptoms of Cushing's disease. Because there was not a group who didn't receive the medication, there were different rates of reductions (lowering) of these symptoms, and blood pressure medications were allowed during this trial, it is not known if these changes were from taking SIGNIFOR or not.

SIGNIFOR dosing

for patients with Cushing’s disease

Twice-daily self-administered injection, or injected by a caregiver

When starting SIGNIFOR twice a day at 0.6 mg or 0.9 mg, a dose increase or decrease twice a day may be considered based on how treatment works and tolerability of the starting dose.

  • With SIGNIFOR you are not required to visit a trained healthcare professional’s office to receive your injection(s)
  • Your healthcare professional will train you or your caregiver on how to inject SIGNIFOR into your thigh or abdomen
  • Refer to the SIGNIFOR Instructions for Use for detailed instructions
  • If you encounter any difficulty giving yourself injection(s), you may receive additional training from a nurse through the R.A.R.E.™ Patient Support Program
Calendar

Twice-daily self-administered injection

What should be told to a healthcare provider before taking SIGNIFOR?

see more

Before you take SIGNIFOR, tell your doctor if you:

  • Have or have had high blood sugar (hyperglycemia)
  • Have diabetes
  • Have or have had heart problems
  • Have a history of low levels of potassium or magnesium in your blood
  • Have or have had liver problems
  • Have or have had gallstones
  • Have any other medical conditions
  • Are pregnant or plan to become pregnant. SIGNIFOR may harm your unborn baby
  • Are breastfeeding or plan to breastfeed. It is not known if SIGNIFOR passes into your breast milk. You and your doctor should decide if you will take SIGNIFOR or breastfeed. You should not do both

Treatment with SIGNIFOR may result in improved fertility and the possibility of unplanned pregnancy in women who have Cushing’s disease and have not gone through menopause. Talk to your healthcare provider about birth control methods that may be right for you during treatment with SIGNIFOR.

Tell a healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

SIGNIFOR and other medicines may affect each other, causing side effects. SIGNIFOR may affect the way other medicines work, and other medicines may affect how SIGNIFOR works. Your healthcare provider may need to change your dose of SIGNIFOR or your other medicines. Especially tell your healthcare provider if you take:

  • Medicines to control your heartbeat (anti-arrhythmics)
  • Medicines that can affect the electrical system of your heart (QT prolongation)
  • Medicines to control your blood pressure (such as beta-blockers or calcium channel blockers)
  • Medicines to control the electrolyte (such as potassium or magnesium) levels in your blood
  • Cyclosporine
  • Bromocriptine

Ask your healthcare provider for a list of these medicines if you are not sure.

Know the medicines you take, and keep a list of them to show your healthcare provider and pharmacist when you get a new medicine.

Diagram
see less

How is SIGNIFOR used?

see more
  • Use SIGNIFOR exactly as your doctor tells you to
  • Your doctor may change your dose if needed
  • Before you use SIGNIFOR for the first time, your doctor should do a blood test to check your blood sugar levels and your liver tests
  • Before you use SIGNIFOR for the first time, your doctor should do a test to check your heart (electrocardiogram) and your gallbladder (ultrasound)
  • SIGNIFOR should be clear and colorless. Before you inject your dose, check to make sure that SIGNIFOR is clear and colorless, and does not have any clumps or particles in it
  • SIGNIFOR is given as an injection into the fat just under your skin (subcutaneous injection)
  • Do not inject SIGNIFOR into skin that is red or irritated
  • The recommended injection sites for SIGNIFOR are the top of your thigh or stomach area (abdomen)
  • Change (rotate) your injection site with each dose. Do not inject SIGNIFOR into the exact same spot for each injection
  • Your doctor should show you how to prepare and give your dose of SIGNIFOR before you use it for the first time
  • You should not inject SIGNIFOR until your doctor has shown you how to use it the right way
  • If you take too much SIGNIFOR, tell your doctor right away

If you experience sudden abdominal pain or pain in your right shoulder or between shoulder blades, yellow eyes, fever with chills, weakness, dizziness, or fainting spells, contact your healthcare provider right away.

Read the instructions provided within the Medication Guide section of the full Prescribing Information for SIGNIFOR.

see less

Most common side effects
of SIGNIFOR include:

  • Diarrhea
  • Nausea
  • High blood sugar
  • Headache
  • Abdominal pain
  • Fatigue
  • Diabetes mellitus
  • Injection-site reactions
  • Common cold
  • Hair loss
  • Weakness
  • Fluid retention

There are other serious side effects that can occur with SIGNIFOR. If you experience sudden abdominal pain or pain in your right shoulder or between shoulder blades, yellow eyes, fever with chills, weakness, dizziness, or fainting spells, contact your healthcare provider right away.

To report SUSPECTED SIDE EFFECTS, contact Recordati Rare Diseases Inc. at 1-888-575-8344,
or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Indications and Usage

SIGNIFOR is a prescription medicine used to treat Cushing’s disease in adults who cannot have surgery or have failed surgery.

Important Safety Information:

Indications and Usage

SIGNIFOR is a prescription medicine used to treat Cushing’s disease in adults who cannot have surgery or have failed surgery.

Important Safety Information: